1. GBD 2017 Causes of Death Collaborators. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018; 392:1736–88.
2. Roth GA, Forouzanfar MH, Moran AE, Barber R, Nguyen G, Feigin VL, et al. Demographic and epidemiologic drivers of global cardiovascular mortality. N Engl J Med. 2015; 372:1333–41.
Article
3. Zhao D. Epidemiological features of cardiovascular disease in Asia. JACC Asia. 2021; 1:1–13.
Article
4. Rodgers JL, Jones J, Bolleddu SI, Vanthenapalli S, Rodgers LE, Shah K, et al. Cardiovascular risks associated with gender and aging. J Cardiovasc Dev Dis. 2019; 6:19.
Article
6. Lloyd-Jones DM, Allen NB, Anderson CA, Black T, Brewer LC, Foraker RE, et al. Life’s essential 8: updating and enhancing the American Heart Association’s Construct of Cardiovascular Health: a presidential advisory from the American Heart Association. Circulation. 2022; 146:e18–43.
Article
7. Siervo M, Lara J, Chowdhury S, Ashor A, Oggioni C, Mathers JC. Effects of the Dietary Approach to Stop Hypertension (DASH) diet on cardiovascular risk factors: a systematic review and meta-analysis. Br J Nutr. 2015; 113:1–15.
Article
8. Ahmed HM, Blaha MJ, Nasir K, Rivera JJ, Blumenthal RS. Effects of physical activity on cardiovascular disease. Am J Cardiol. 2012; 109:288–95.
Article
9. Hackshaw A, Morris JK, Boniface S, Tang JL, Milenkovic D. Low cigarette consumption and risk of coronary heart disease and stroke: meta-analysis of 141 cohort studies in 55 study reports. BMJ. 2018; 360:j5855.
Article
10. Wang D, Li W, Cui X, Meng Y, Zhou M, Xiao L, et al. Sleep duration and risk of coronary heart disease: a systematic review and meta-analysis of prospective cohort studies. Int J Cardiol. 2016; 219:231–9.
Article
12. Ettman CK, Abdalla SM, Cohen GH, Sampson L, Vivier PM, Galea S. Prevalence of depression symptoms in US adults before and during the COVID-19 pandemic. JAMA Netw Open. 2020; 3:e2019686.
Article
13. Fuzeki E, Groneberg DA, Banzer W. Physical activity during COVID-19 induced lockdown: recommendations. J Occup Med Toxicol. 2020; 15:25.
Article
14. Garcia S, Albaghdadi MS, Meraj PM, Schmidt C, Garberich R, Jaffer FA, et al. Reduction in ST-segment elevation cardiac catheterization laboratory activations in the United States during COVID-19 pandemic. J Am Coll Cardiol. 2020; 75:2871–2.
Article
15. Kim E, Jung CH, Kim DJ, Ko SH, Lee HY, Lee KY, et al. Changes in cardiovascular-related health behaviors during the COVID-19 pandemic. Cardiovasc Prev Pharmacother. 2023; 5:15–23.
Article
16. Yoon J, Yoon SJ. Quantifying burden of disease to measure population health in Korea. J Korean Med Sci. 2016; 31 Suppl 2(Suppl 2):S101–7.
Article
17. Lim S, Lim H, Despres JP. Collateral damage of the COVID-19 pandemic on nutritional quality and physical activity: perspective from South Korea. Obesity (Silver Spring). 2020; 28:1788–90.
Article
18. Ferrante G, Camussi E, Piccinelli C, Senore C, Armaroli P, Ortale A, et al. Did social isolation during the SARS-CoV-2 epidemic have an impact on the lifestyles of citizens? Epidemiol Prev. 2020; 44(5-6 Suppl 2):353–62.
19. Pecanha T, Goessler KF, Roschel H, Gualano B. Social isolation during the COVID-19 pandemic can increase physical inactivity and the global burden of cardiovascular disease. Am J Physiol Heart Circ Physiol. 2020; 318:H1441–6.
20. Aldwin C, Stokols D. The effects of environmental change on individuals and groups: some neglected issues in stress research. J Environ Psychol. 1988; 8:57–75.
Article